First, let’s get the psychologist’s background on this test.

March 2026 saw the US Food and Drug Administration grant breakthrough device designation to Path Assist Derm, an artificial intelligence (AI) tool that enhances pathology workflows by analysing whole ...

The Journal of the Alzheimer's Association, could help better diagnose dementia patients with the correct pathology, ...

Thyrocare Technologies Limited Q4FY26 results show strong revenue and profit growth, record test volumes, quality gains and ...

The idea is straightforward: Take a blood test now, even without symptoms, and learn if you could some day develop ...

Imagine a 62-year-old woman who aces every memory test her doctor gives her. Her brain scans look clean. She feels sharp. But ...

Right breast cancer pathway discipline embeds testing early to guide treatment decisions and improve care consistency across health systems.

Acurion, a precision oncology technology company developing AI-driven approaches to cancer biomarker detection, today announced that Co-Founder and Board Member Magda Marquet, Ph.D., will participate ...

CancerCheck is a one-of-a-kind early-detection blood test that, for the first time, can extract whole circulating tumor cells (CTCs), enabling a board-certified pathologist to ...

A new study​ finds that a simple blood test could predict Alzheimer's disease long before symptoms appear.

The government is actively committed to extending the national healthcare network, ensuring that skilled medical ...

When patients visit Womack Army Medical Center (WAMC) and the outlying clinics, they typically interact with doctors, nurses, ...